initi w/market perform focus chang histori sales-wis
initi coverag market perform rate nvent technic product
segment spun april
believ break-up enhanc organ sale growth nvent keener focu best
opportun vertic favor expect margin held back near term
price-cost execut issu near term longer term spend product
save sale initi
expect ep growth
macro sector updat
edit one stock one theme report seri take closer look success
investor focu tend product sale believ highli profit recur
natur servic segment warrant attent despit rapid industri move public
cloud analysi suggest overal instal base continu grow ultim translat
increas servic contract solid growth
reiter outperform rate
report prepar part analyst employ canadian affili bmo nesbitt burn inc
uk affili bmo capit market limit authoris regul financi servic
author uk regist research analyst finra rule
disclosur statement includ analyst certif pleas refer page
jame fotheringham us large-cap bank specialti financ
new leverag target roughli expect
follow ainv in-lin result rais estim lower/ti manag fee
structur maintain target upsid exclud yield target impli p/
yield line industri averag exhibit
new leverag target debt/equ line forecast although
previous model quicker start rise leverag
absolut valu share depreci anticip rise st rate given forecast
higher fed fund stock continu under-perform subsector within
az tough matur high profit franchis erod crestor invest
new launch oncolog growth opportun china
believ headwind gradual subsid
growth potenti becom appar look ahead guidanc fine
increment posit lynparza prostat imfinzi/trem sclc number catalyst seem
believ az verg strong growth remain top growth pick
highlight disclosur ci file relat pend ci-esrx merger among
year forward project ci esrx stand-alone result well esrx project post-
merger synergi expect higher provid ci
gener find disclosur encourag relat stand-alone post-
merger outlook higher formal guidanc even adjust compar basi
make ci/esrx target ep look bit achiev
updat estim follow quarter ivq continu expand platform
ivq product first half doubl size portfolio ad
anoth properti segment mob new develop relationship
think compani well posit go forward expect growth improv
maintain outperform rate invesqu base attract fulli cover yield
discount valuat affo discount nav/sh estim
jeffrey silber busi industri servic
recent investor meet manag provid insight issu face
busi transform plan progress
benefit like take time play believ right track
although believ true publicli held pure play comp stock trade fairli close
hazard wast peer metric except forward-look price-to-earnings trade
believ may attract invest opportun patient deep-valu investor
food retail distribut take-away bmo market confer
follow annual market confer last week provid take-away
meet compani across food retail distribut coverag includ kr
well industri present iri technom
provid five key take-away meet total point includ thought
biggest new announc ocado partnership key overarch theme
modest model tweak market perform-r kr
usual monthli report offer two thing first point set four common
topic popular incom question answer bodi report upcom
catalyst idea focus late favorit read past month
second bodi varieti data point track commentari potenti
earn impact cover compani includ takeaway non-cov compani
call nielsen tv rate cabl network subscrib internet metric index
sensortow app download agenc account move theatric offic number
produc sound increasingli confid tone multi-year outlook lumber
osb pulp capital-expenditure budget trend upward primarili lumber produc us
wood product firm appear head cyclic windfal use cash wise
track record capit alloc great
maintain neutral stanc timber wood product compani rel full
valuat acknowledg look like impress year perhap best ever
attend micron analyst day upcom week
topic would like see addressed/answ event
bottom line produc sound increasingli confid tone multi-
year outlook lumber osb pulp capital-expenditure budget trend upward primarili
lumber produc us south wood product firm appear head
cyclic windfal use cash wise track record capit alloc
great maintain neutral stanc timber wood product compani
rel full valuat acknowledg look like impress year
perhap best ever
beyond belief mani us one promin ceo note discuss
lumber market lumber make new high hous start north
start varieti factor appear work
heard suggest rail-rel inventori back-up western canada
begun abat past week howev consensu
clear lumber panel inventori would drag late best west fraser
ceo ted seraphim note compani endur tough april predict
wft would ship lumber produc
produc sound increasingli confid multi-year outlook
lumber osb pulp wft-cn note rethink long-term trend price
assumpt w-spf lumber suggest number would start
osb delay ramping-up new restart mill allow time
offset growth demand heard similar optim around pulp global
forecast new capac low
capital-expenditure budget trend upward especi us south lumber
produc summit outlin meaning debottleneck plan sever compani
studi expans beyond announc program canfor interfor least one
larg privately-held compani reportedli studi greenfield sawmil project
appear head impress cyclic windfal use wise
messag return capit often vagu perhap understand
track record cyclic wood product produc buy back stock amidst strong
market isnt pretti compani cautiou over-extend dividend
basi strong market meet hint
special dividend end day best cours may disciplin build
cash good time order opportunist bad time
report rais estim also boost
target price maintain market perform rate
research help appreci consider
market confer
bottom line follow annual market confer last week
provid take-away meet compani across food retail
distribut coverag includ kr well
industri present iri technom provid five key take-away
meet total point includ thought biggest new
announc ocado partnership key overarch theme modest
model tweak market perform-r kr
biggest new announc stake ocado thursday
announc reach agreement partner on-line supermarket ocado
bring ocado first time partner exclus
clearli expand capabl digit arsen clicklist same-day deliveri
power instacart estim like deliveri power
ocado yet remain market perform-r
theme includ pressur freight rate gener stabil
also echo ftr wage could result food inflat
kr still invest price independ outpac chain
restaur also conveni store channel accord
contrari food retail believ larg discount chain gain
disproportion amount share see food retail capac analysi on-line
deliveri option continu evolv rapid pace food retail kr ocado
may test click collect urban trend outpac rural commun see
comment echo trend compani continu
make invest technolog digit capabl
model chang kr tweak model adjust time
expens though full-year ep remain unchang kr tweak model
weaker comp stronger comp given commentari id expect
ramp throughout year
bmo outperform-r stock remain outperform-r target
price foodservic distributor includ target price target
price target price target price target price
bottom line attend micron analyst day upcom
week topic would like see addressed/answ event
micron expect compani continu sound posit tone
memori industri stanc share micron remain chase
cyclic stock top cycl sure dram cycl like mute
industri consolid nand new entrant
meanwhil price increas dram moder nand price
top concern heard investor continu around
oper leverag opex especi relat oper model
look y-o-i increas annual opex expect compani
expand vision transform fpga provid one
offer platform/cap across multipl applic hardwar softwar
programm continu rate share outperform
expect compani provid updat oper model growth
driver busi especi baw portfolio also expect compani
discuss path gross margin expans hope better predict rate
research help appreci consider
bottom line edit one stock one theme report seri take
closer look success servic busi investor focu tend
product sale believ highli profit recur natur
servic segment warrant attent despit rapid industri move
public cloud analysi suggest overal instal base continu grow
ultim translat increas servic contract solid growth reiter
outperform rate
strong fundament believ success servic busi often goe
overlook especi consid segment industri lead fundament
gross margin significantli higher network peer
resembl secur softwar compani busi also impress given
high percentag recur revenu strong attach rate product sale
base model assum product growth servic growth long term
instal base continu expect growth compani instal base larg
driven increas product lifespan strong growth virtual adc believ
instal base key driver servic revenu initi attach rate
mean increas servic contract contract receiv servic revenu
roughli equal product asp sale estim
aw threat secret market slow recent year
report market share come pressur larg stem aw
growth aw clearli hurt market share standpoint believ vast
major share loss low end market necessarili
part market compani target therefor believ threat
aw overblown
valuat believ ev/fcf multipl appropri way think
valuat especi given close similar busi
secur vendor new price target assum share trade
ev/fcf estim line peer group
research help appreci consider
product refresh posit impact yet
believ cycl littl close
last one could see benefit
believ beneficiari
new tax reform within coverag lower
tax rate increas buy-back repatri
potenti ad ep estim
use invest
chang
total liabil share equiti
price target assum share trade ev/fcf
estim
upsid case target base
million target multipl ev/fcf upsid
case includ addit bp revenu growth
addit bp margin expans versu
base case assumpt
comparison downsid case target
base million target multipl
ev/fcf case assum reduct
revenu growth bp less oper margin
versu base case assumpt
usd
sever new product releas softwar
hardwar offer help spur custom demand
next quarter
provid applic deliveri network
technolog ensur secur optim
avail applic within network core
technolog base programm scalabl os
known tmo run compani hardwar
virtual offer includ big-ip viprion software-
bottom line usual monthli report offer two thing first point
set four common topic popular incom question answer
bodi report upcom catalyst idea focus late
favorit read past month second bodi varieti
data point track commentari potenti earn impact cover
compani includ takeaway non-cov compani call nielsen
tv rate cabl network subscrib internet metric index
sensortow app download agenc account move theatric offic
number boxofficemojo
four popular incom question answer within back
normal fb recov post ca ecomm tax tweet late etc
thought cb viab head expect
review buyer bad
four catalyst monitor fb move date potenti
implic media next step outcom delawar court
proceed cbs/viab t/twx vs doj decis secretari state
decis foxa-ski expect dis-foxa track summer sharehold
meet bar competit bid idea upcom confer
code confer may vidcon june googl market live
juli googl cloud juli ebay open juli
enforc gdpr may
four idea focus whether would rethink use
mid long term cloud youtub hardwar lower margin
search second wave growth driver quickli state turn
legal sport gambl much may boost sport viewership especi
nfl busi media internet compani creat capit
 extens fantasi franchis cb espn yhoo/vz bet facilit built
ott platform opportun ticketmast stubhub etc
potenti domino media t/twx proce revisit bid
addit current bid hulu potenti bargain chip larg
agenc review start get settl like marriott
new larg one like daimler gsk revlon also ad
four favorit read past month insid ecosystem fuel
paid imperson quartz shari redston plot breed cb viacom
research help appreci consider
nielsen tv rate disney turner cb
viacom nbc univers discoveri
nielsen cabl network subscrib estim
internet metric app download data
spent index global app
download sensor tower varieti genr
agenc account move report
advertis trade magazin includ move
theatric offic boxofficemojo
soni lionsgat among other
bottom line highlight disclosur ci file relat pend ci-
esrx merger among year forward project ci esrx stand-alone
result well esrx project post-merg synergi expect
higher provid ci gener find disclosur encourag
relat stand-alone post-merg outlook higher
formal guidanc even adjust compar basi make ci/esrx
target ep look bit achiev
rel strong earn forecast ci esrx
forecast ci stand-alone ep would presum higher
adjust reflect improv outlook mid-
point ci guidanc reflect figur includ
project share repurchas guidanc estim one-
third oper upsid anoth refer point our/street current ep
reflect improv outlook exclud share repurchas
suspend pend merger
higher long-term view well ci stand-alone ep project
vs ci prior stand-alone target street stand-alone
esrx ep project vs current street reflect
esrx view earn growth despit recent challeng
ci modestli higher view merger synergi take-away
meet ci host last week path improv sentiment ci/
esrx may highlight ci improv articul clear path
ep base oper cost synergi alon specif
target ci forecast direct consist
unround figur bit higher
revenu synergi would upsid
much higher view synergi esrx forecast sell parti
deal surpris esrx-project synergi higher even
magnitud would expect
assum inclus revenu synergi
research help appreci consider
global health care busi well posit
least ep growth reach state target
ep view near term cigna
relaunch growth continu rebuild
profit group insur set deploy capit
least billion acceler growth howev
compani slower-growth commerci mix keep us
sidelin
total liabil share equiti
target price base ep
current sector market-cap weight
averag price-to-earnings target expect increas
investor visibl confid recent announc
ep remain sidelin
appar investor sentiment around pend esrx
ci upsid scenario base target price-to-earnings
ep modestli current
estim scenario entail success one
acquisit drive ep upsid also
increas investor sentiment toward long-term growth
downsid scenario base target price-to-earnings
ep current estim
scenario entail precis defin execut laps
ci wake misstep group
usd
earn medic cost trend
corpor togeth subsidiari
dental disabl life accid insur relat
product servic compani oper three
benefit group disabl life
new leverag target roughli
bottom line follow ainv in-lin result rais estim lower/
tier manag fee structur maintain target upsid exclud
yield target impli p/nav yield line industri averag
exhibit new leverag target debt/equ line forecast
although previous model quicker start rise leverag absolut
valu share depreci anticip rise st rate given forecast
higher fed fund stock continu under-perform subsector within
line ainv core noi per share line estim
miss consensu lower-than-expect dividend incom off-set
lower manag fee expens declin per share last
quarter leverag fell debt-to-equ last quarter
rais estim lower fee cost maintain core noi per share estim
rais forecast due lower
manag fee new fee structur introduc off-set partial lower
interest dividend incom later start rise leverag
leverag guidanc ainv increas target leverag debt/equ
april take month reach new target
previous model quicker start rise leverag lower estim
respect five
bdc cover sbcaa reaction mix ainv approv applic
higher leverag arcc recommend approv cct ocsl psec stand pat
unchang target price predic discount multipl
target yield slightli industri averag exhibit
consid peg ainv target closer per share demonstr
return stabl growth inflat expect dissip els equal
invers relationship rate share price perform apart
market-neutr pair trade within subsector hesit recommend
purchas share long fed fund rise sinc incept
spbdcup perform typic neg advanc rise short-term interest rate
us large-cap bank specialti financ
target price impli upsid ainv share
exclud dividend yield howev
forese headwind share price appreci
rise short-term interest rate absolut valu
share correl invers rate expect
lack expect growth per share
year next year year
target price predic discount
multipl deriv target dividend yield
assum ainv share trade
assum ainv share trade
usd
ainv catalyst stock howev share
prove valuation-sensit chang rate agenc
attitud relat new leverag limit well
market expect interest rate corpor credit
apollo invest corp oper busi
develop compani apollo portfolio primarili
compris debt invest includ senior secur
loan subordin mezzanin invest well
equiti privat middle-market compani
bottom line az tough matur high profit franchis erod crestor
invest new launch oncolog growth opportun china
believ headwind gradual subsid
growth potenti becom appar look ahead guidanc fine
increment posit lynparza prostat imfinzi/trem sclc
number catalyst seem underappreci lynparza roxadustat anemia
farxiga cvot believ az verg strong growth remain top growth
tough quarter reflect point maximum pressur az
margin growth kick revenu line consensu
forecast lower extern revenu expect
pharma sale consensu mostli crestor in-lin
forecast gross margin forecast reflect number
factor resolv time crestor loe biolog uptak one time item
 expect sg expect
reflect az launch effort invest china tax rate higher
expect line guidanc lower extern revenu gross
margin along higher sg tax rate drove ep miss vs
consensu bmo respect az maintain guidanc remain
achiev heavier contribut
long-term growth margin expans thesi remain intact
impact crestor loss exclus loe annual import growth
driver intact perform line better expect tagrisso
imfinzi lynparza farxiga okay higher sg particularli given
recent trend perform china remain strong lower sale
em could explain divest asset primari care busi declin
oncolog specialti franchis ramp see oper margin
expans becom evid particularli expens big trial wrap
 farxiga cvot
research help appreci consider
az focus strategi produc potenti
best-in-class growth profil leadership
forecast revenu ep compound-annual-growth-rate
respect primarili driven oncolog
franchis az number potenti posit near-
product sold
provis incom tax
earn tax ifr
dividend sharehold
net chang
short-term invest
short-term debt leas
long-term debt leas
total liabil share equiti
target base weight averag
dcf price-to-earnings ep
believ price-to-earnings appropri az growth
profil revenu ep compound-annual-growth-rate
respect howev given emphasi az longer-
term growth prospect uncertainti near-term
estim extern revenu place greater
weight dcf
franchis reach acalabrutinib show
meaning better clinic profil vs imbruvica cll
gener az growth profil
improv revenue/ep compound-annual-growth-rate respect
mystic trial fail acalabrutinib fail vs
imbruvica lead significantli lower oncolog
revenu limit margin expans
az would grow revenu ep
respect share would trade pe
usd
lynparza ovarian cancer durva /- treme
head neck cancer mystic overal surviv os
roxadustat mace outcom
promin catalyst head head
trial readout acalabrutinib vs imbruvica cll
astrazeneca plc az global bio-pharmaceut
compani headquart cambridg nyse
ticker azn az form merger
astra ab zeneca plc az focus three main therapi
area oncolog cardiovascular metabol diseas
cvmd respiratori az gener revenu
core net incom
expand platform
bottom line ivq product first half doubl size
portfolio ad anoth properti segment mob new develop
relationship think compani well posit go forward expect
growth improv maintain outperform rate invesqu base
attract fulli cover yield discount valuat affo
discount nav/sh estim
partnership ellipsi estat partner develop senior hous mob
properti base carmel indiana ivq right oblig
purchas complet develop project ellipsi provid mezzanin
financ develop ellipsi five develop way michigan
indiana expand mezzanin lend program key prioriti
invesqu allow compani earn high return mezz fund
mohawk may invesqu complet acquisit mohawk reit mob owner
oper canada million compani expect grow
portfolio target yield focus multi-ten off-campu
properti secondari market mob diversifi ivq revenu mix
tenant credit metric ivq trail ebitdar leas coverag ratio
stabl q/q ebitdarm coverag ratio rose modestli occup
ttm q/q
financi posit ivq debt-to-total-asset ratio
line compani target ivq averag interest
rate debt
ivq debt fix rate vs includ impact
discount valuat ivq trade affo discount
estim compar favour -list peer
report prepar analyst employ bmo nesbitt burn inc
regist research analyst finra rule
prem/ disc
note figur us unless state reflect
partial year prior estim includ impact busi
combin cost exclud current
outperform rate invesqu base
potenti affo growth acquisit
contractu rent bump attract yield
discount valuat compar
target price base premium
estim equal affo target
premium affo multipl line
healthleas properti reit prior take-out
think justifi given proven manag team
upsid scenario invesqu would
share equal premium estim
repres high end valuat rang
healthleas properti reit prior take-over upsid
downsid scenario invesqu discount
estim equal affo
yield valuat level low end
valuat rang reit prior
take-over pleas note diagram illustr
usd
increas sector
invesqu canadian-list compani focus senior
hous invest canada invesqu
owner oper facil leas
third-parti oper long-term basi invesqu trade
 dollar pay dollar dividend
bottom line recent investor meet manag provid insight
issu face busi transform plan progress
benefit like take time play believ right
track although believ true publicli held pure play comp stock
trade fairli close hazard wast peer metric except forward-
look price-to-earnings trade sizabl discount believ may attract
invest opportun patient deep-valu investor
outlin busi transform strategi improv long-term perform
full benefit like felt believ compani
alreadi see benefit effici initi howev
plan erp implement add sizabl risk potenti disrupt roll-
though manag believ learn mani lesson fail
implement much custom hope minim
potenti portfolio ration next month manag
plan ration srcl vast portfolio manag state view two
servic line regul wast complianc servic rwc
medic wast secur inform destruct servic sid core
though could divestitur geographi area may
make sens remain scale issu manag provid
addit insight believ like divestitur could occur
two segmentscommun relat servic manufactur
industri servic believ gener profit compani
attract valuat certain metric though truli pure play
comp trade roughli line hazard wast stock
metric except ntm price-to-earnings trade sizabl discount like sinc
exclud rel higher leverag nevertheless believ may
attract invest opportun patient deep-valu investor manag
reduc volatil increas predict overal busi
research help appreci consider
busi industri servic
compani diversif sector
reduc health care end-market risk
medic wast still largest end market face
issu price pressur industri consolid
ep share os
provis benefit inc tax
chang work capit
short long-term debt
growth margin data
averag forward-look price-to-earnings ev/ebitda free cash flow
per share discount cash flow base forward-
upsid assum multipl expans forward-look
per share estim higher
downsid assum multipl contract forward-
look per share estim lower
usd
wast price volum trend health care industri
btob servic provid
focu regul complianc solut health care
retail commerci busi
initi w/market perform focus chang
bottom line initi coverag market perform rate nvent
technic product segment spun-off april believ
break-up enhanc organ sale growth nvent keener focu
best opportun vertic favor expect margin held back
near-term price-cost execut issu near-term long-term
spend product save sale initi present expect ep
growth
new coverag initi coverag w/a market rate manufactur electr
protect heat trace electr fasten ground product industri
commerci resi infrastructur market expect slight declin pro-forma
ep growth pt deriv appli
multipl ep ebitda
histor speak last year organ sale averag
unremark spin-off aim drive valu ntv management focus
increas sale make acquisit segment margin increas
sens management margin view secondari driver valu
sale growth exceed histor level management craft mani sale
strategi includ leverag lead brand channel spend increas
npd veloc penetr int market captur benefit secular/mega trend
price vertic posit organ sale guid lt goal
exceed histor estim
less optimist margin employ product program lower
cost believ like spend save sale initi management
expect flat om lt goal margin expans metric
inspir om slightli guidanc ep low
end guid rang view leverag door open deal
expect management oper
turn us posit need see execut issu enclosur ef
resolv effici sale spend allow product aid margin
research help appreci consider
nvent spin busi
technic product segment histor
gener littl sale growth peer-lik margin
manag aim drive valu princip
sale growthwhich expectand small deal
expect littl om expans pedestrian ep
growth
ep oper
believ trade discount capit
good industri stock owe lack track record
view earn growth trail peer
target multipl peer ep
ebitda appli multipl
ep ebitda blend valuat impli
bull case ep ebitda
respect appli multipl
estim blend valuat impli driver
bear case ep ebitda
appli multipl estim
blend valuat impli driver slower sale
usd
acceler organ sale resolut intern issu
nvent billion manufactur enclosur box
cabinet heat trace system electr fasten
tension connect ground product varieti
applic came public spin-off
april
